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Lymphoproliferation in CTLA-4±Deficient Mice
Is Mediated by Costimulation-Dependent
Activation of CD41 T Cells
The role of CTLA-4 in these processes is just begin-
ning to be appreciated. A blockade of CTLA-4/B7 with
intact anti-CTLA-4 antibodies or Fab fragments aug-
mented T cells responses in vitro (Walunas et al., 1994,
1996; Krummel and Allison, 1995), suggesting that this
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blockade prevented an inhibitory signal. This possibilityUniversity of California, Berkeley
was confirmed more directly by antibody cross-linking;Berkeley, California 94720
stimulation of CD41 and CD81 lymph node T cells in
vitro through TCR/CD3 plus CD28 was inhibited when
CTLA-4 was concurrently cross-linked using antibody-
Summary
coated beads or soluble antibodies (Walunas et al.,
1994; Krummel and Allison, 1995). CTLA-4 cross-linking
CTLA-4±deficient animals develop a fatal lymphopro- on T cells stimulated under these conditions down-regu-
liferative disorder. The cellular mechanism(s) respon- lated the expression of activation antigens and IL-2 syn-
sible for this phenotype have not been determined. thesis and inhibited progression into the S/G2 phase of
Here, we show that there is a preferential expansion the cell cycle (Krummel and Allison, 1996; Walunas et
of CD41 T cells in CTLA-42/2 mice, which results in a al., 1996). These data suggest that CTLA-4 plays a criti-
skewing of the CD4/CD8 T cell ratio. In vivo antibody cal role in regulating CD41 and CD81 T cell responses.
depletion of CD81 T cells from birth does not alter the Furthermore, blockade of CTLA-4/B7 interactions in vivo
onset or the severity of the CD28-dependent lympho- alleviates inhibitory signaling and results in augmented
proliferative disorder. In contrast, CD41 T cell deple- antigen-, superantigen- (Kearney et al., 1995; Perrin et
tion completely prevents all features characteristic of al., 1995, 1996; Krummel et al., 1996; Hurwitz et al., 1996;
the lymphoproliferation observed in CTLA-4±deficient Karandikar et al., 1996), and tumor-specific responses
mice. These results demonstrate that CD41 T cells (Leach et al., 1996; Kwon et al., 1997).
initiate the phenotype in the CTLA-42/2 mice. Further, Mice carrying a null mutation in the ctla-4 gene rapidly
these results suggest that the role of CTLA-4 in periph- develop a lymphoproliferative disorder characterized by
eral CD41 versus CD81 T cell homeostasis is distinct. polyclonal T cell activation and generation of a high
frequency of blasting T cells expressing activation/
Introduction memory T cell surface antigens (CD691, CD251, CD44hi,
Mel14lo, and CD45RBlo) (Tivol et al., 1995; Waterhouse
et al., 1995; Chambers et al., 1996). Lymphocytic infil-Optimal T cell activation requires two signals. Signal
trates are apparent in many nonlymphoid organs, partic-one is transducedupon the T cell antigen receptor (TCR)
ularly the heart, liver, and pancreas, and the mice die atbinding to major histocompatibilitycomplex (MHC)/pep-
21±28 days of age. Alterations in the thymocyte subsetstide ligand on antigen-presenting cells (APC). T cell acti-
were observed in initial studies of CTLA-42/2 mice (Tivolvation is influenced by the affinity and duration of the
et al., 1995; Waterhouse et al., 1995); however, it appearsTCR-MHC/peptide ligand interaction. Coreceptors CD4
that differentiation and proliferation of the thymocyteand CD8 appear to influence the rate of dissociation of
subsets proceed normally until the mice become visiblythe T cells and APC and to colocalize proteins involved
ill (Chambers et al., 1997). Also, mature CD4 SP thymo-in signal transduction to the site of the TCR engagement
cytes appear to behave normally when stimulated via(reviewed by Janeway and Bottomly, 1994). Signal 2
the TCR/CD3 complex (Chambers et al., 1997). However,or costimulation provides an independent stimulus that
a large proportion of the peripheral T cells are activatedinfluences the outcome of the T cell/APC interaction.
in CTLA-42/2 animals as young as 5±6 days old (unpub-Recently, it has been shown that negative as well as
lished data), suggesting that recent thymic emigrantspositive costimulation plays an important role in control-
become activated almost immediately uponentering theling T cell activation and peripheral T cell homeostasis
periphery. The phenotype of the CTLA-42/2 mice dem-(reviewed by Thompson and Allison, 1997). These pro-
onstrates convincingly the functional importance ofcesses are mediated by CTLA-4 and CD28 upon interac-
CTLA-4 for regulating T cells in vivo.tion with the shared ligands CD80 (B7.1) and CD86
The basis for the peripheral T cell activation in CTLA-(B7.2). CD28-mediated costimulation enhances T cell
42/2 mice is unknown. Studies of the mice generated inproliferation and interleukin (IL)-2 synthesis, and it in-
our laboratory consistently revealed a skewing of theduces anti-apoptosis protein Bcl-xL. The requirement
CD4/CD8 ratio toward CD4. Further, there was a higherfor CD28 for optimal T cell activation has been demon-
percentage of CD41 than CD81 T cells that displayedstrated for both CD41 T cells and CD81 T cell clones
activation markers and incorporated the thymidine ana-and freshly isolated T cells (Azuma et al., 1992; Harding
log bromodeoxyuridine (BrdU), suggesting that theet al., 1992; Harding and Allison, 1993; reviewed by Lin-
CD41 T cells were preferentially activated. To determinesley and Ledbetter, 1993; Lenschow et al., 1996).
whether the absence of CTLA-4 had differential effects
on CD41 and CD81 T cells, we examined the effects of
CTLA-4 deficiency in vivo by continuous depletion of*To whom correspondence should be addressed (e-mail: jallison
@uclink4.berkeley.edu). CD41 or CD81 T cells from birth. Although the depletion
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CD8 subset distribution in the T cell population of CTLA-
42/2 mice was not unique to the genetic background of
the 129 3 B6 F1 intercross, although the onset of an
abnormal T cell subset ratio appeared to be delayed in
the F4 BALB/c CTLA-42/2 mice and was more pro-
nounced in the spleen. As will be discussed below, there
was an increase in the absolute number of both CD41
and CD81 T cells in the lymph node and spleen of the
CTLA-42/2 animals, but there was a smaller increase
in the number of CD81 peripheral T cells (see below;
Figure 3).
Figure 1. Skewing of the CD4/CD8 Ratio toward CD41 T Cells
Representative FACS profiles and the total number of the lymph Skewing of CD4/CD8 Ratio toward CD41 T Cells
node cells from a 24-day-old CTLA-42/2 animal and littermate in CTLA-42/2 Mice Is Not Caused by an
control.
Inherently Faster Turnover of CD41
Versus CD81 T Cells in Normal Mice
A larger expansion of CD41 T cells compared to CD81
of CD81 T cells did not alter the onset or the severity T cells may result from an increased production of CD41
of the lymphoproliferative disorder in CTLA42/2 mice, T cells in the CTLA-42/2 mice. Previously, we have
CD41 T cell depletion completely prevented the lympho- shown that the onset of the lymphoproliferative disorder
proliferative phenotype. Moreover, the CD81 T cells in in the periphery occurred prior to any phenotypic
the CD41 T cell±depleted animals had a naive pheno- changes in the thymus (Chambers et al., 1997). Further,
type, indicating that these cells had not been activated incorporation of thymidine analog BrdU in vivo demon-
in vivo. Activation of CD41 T cells in the CTLA-42/2 mice strated that there was no alteration in the production
required CD28-mediated costimulation. Collectively, of single, positive thymocytes in the CTLA-4±deficient
these results demonstrate that there are differential animals (Chambers et al., 1997). These results indicate
thresholds for activation of CD41 and CD81 T cells in that the augmented expansion of the CD41 T cell com-
the absence of CTLA-4. Because CTLA-4 is expressed partment was not due to altered thymocyte differentia-
on both CD41 and CD81 T cells in normal mice, these tion and that the altered CD4/CD8 ratio occurred in the
results suggest that there may be differences in the periphery.
mechanisms involved in maintaining homeostasis of pe- Because polyclonal T cell activation and proliferation
ripheral CD41 and CD81 T cells. occurs in CTLA-4±deficient mice, the skewing of the
CD4/CD8 ratio might occur simply as a result of inherent
differences in the normal turnover of CD41 versus CD81Results
T cells in theseyoung animals.To test this possibility, we
examined the incorporation of BrdU into the lymphocyteSkewing of the CD4/CD8 Ratio toward
populations of young normal animals in vivo. AnimalsCD4 in CTLA-42/2 Mice
were injected every 12 hr with 1 mg of BrdU for 2 days.CTLA-4±deficient animals succumb to a fatal lympho-
Treated animals were then analyzed 12 hr or 7 daysproliferative disorder as a result of polyclonal T cell acti-
after the last injection. As shown in Figure 2, peripheralvation and expansion (Tivol et al., 1995; Waterhouse et
CD81 T cells consistently showed greater labeling withal., 1995). It was originally concluded that the relative
BrdU following a 2-day pulse, indicating that more CD81proportions of CD41 versus CD81 T cells are not altered
cells had undergone DNA synthesis than CD41 T cellsin the CTLA-42/2 mice (Tivol et al., 1995; Waterhouse et
during this period. Following a 7-day chase, fewer ofal., 1995), but a recent report indicates that CD4/CD8
the CD81 T cells in the lymph node and the spleen wereratios of 6:1 were indeed observed in these mice (Water-
BrdU1 compared to the CD41 T cells, and the remaininghouse et al., 1996). Mice homozygous for a null mutation
positive population was BrdUlo, demonstrating thatin CTLA-4 generated in our laboratory (Chambers et al.,
CD81 T cells have a more rapid turnover in young ani-1997) demonstrated a dramatic shift in the CD4/CD8
mals (Figure 2). Thus, the skewing of the CD4/CD8 ratioratio (Figure 1). Littermate controls had a CD4/CD8 ratio
toward CD41 T cells was not likely caused by an inher-of 2:1 to 3:1 (n . 60), whereas the CTLA-42/2 animals
ently higher rate of division by CD41 T cells.consistently had altered CD4/CD8 ratios by 14 days of
age (n 5 10). The skewing of the ratio became more
dramatic over time, with ratios of 6:1 to 20:1 for CD41 Depletion of CD41 T Cells Prevents
Lymphoproliferative Disorderto CD81 T cells being observed in CTLA-42/2 animals
21±28 days of age (n 5 30). There was no dominant TCR in CTLA-42/2 Mice
Collectively, these results suggest that the absence ofVb expressed on the activated T cells (Chambers et al.,
1997), suggesting that the CD4/CD8 skewing was not CTLA-4 has a differential effect on CD41 compared to
CD81 T cells. Moreover, these results suggest that CD41the result of a particular environmental antigen. Bias
toward CD41 T cell expansion was observed in 129 T cells may be more important than CD81 T cells for
the lymphoproliferative disorder observed in the CTLA-3 C57BL/6 mice, as well as in animals that had been
backcrossed five times to C57BL/6 or 129/SvJ and four 4±deficient mice. To examine this possibility, mice were
depleted of CD41 or CD81 T cells by antibody treatmenttimes to BALB/c; this indicates that this abnormal CD4/
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Figure 3. CD41 T Cell Depletion Prevents Lymphocyte Expansion
in CTLA-4±Deficient Mice
(A) Absolute number of CD41 T cells in control antibody-treated and
CD81 T cell±depleted CTLA-42/2and littermate animals.
(B) Absolute number of CD81 T cells in control antibody-treated
and CD41 T cell±depleted animals. Mice were treated with control,
Gk1.5, or 2.43 antibody from birth. Single-cell suspensions were
prepared from the spleen and lymph nodes; stained for CD4, CD8,
and TCR antibody; and the absolute numbers of each subpopulation
were determined. Each dot represents a single animal. Control anti-
body-treated: CTLA-4 1/1, 1/2, n 5 25; CTLA-42/2, n 5 17; CD81 T
cell±depleted: CTLA-41/1,1/2, n 5 40; CTLA-42/2, n 5 8; CD41 T
Figure 2. CD81 T Cells Have a Faster Turnover Rate Compared to cell±depleted: CTLA-41/1,1/2, n 5 24; and CTLA-42/2, n 5 9.
CD41 T Cells in Normal Mice
The incorporation of BrdU was determined in CD41 and CD81 T
cells in the(A) lymph node and(B) spleen after a 2-day pulse followed
node (Figure 3A) and spleen (data not shown) in theby a 7-day chase. Mice (12 days old) were analyzed after a 2-day
CD81 T cell±depleted CTLA-42/2 mice was approxi-BrdU pulse (injected every 12 hr for 2 days with 1 mg of BrdU/
injection) or 7 days following the BrdU injections. Single-cell suspen- mately 10-fold higher than the number of CD41 T cells
sions were prepared and cells were stained with the antibodies to in CTLA-41/1,1/2 littermates, similar to the increase ob-
the indicated cell surface markers and fixed and stained with anti- served in the control CTLA-42/2 mice.
BrdU antibody. In contrast, when mice were depleted of CD41 T cells,
there was no difference in the total cell number or abso-
with rat anti-mouse CD4 or CD8 antibodies. Litters of lute number of T cells in the CTLA-42/2 mice compared
mice were injected with anti-CD4, anti-CD8, or control to the littermate mice injected with control antibodies
antibody every second day commencing 2 days after (Figure 3B), clearly demonstrating the predominant role
birth. Animals were analyzed individually between 14 of CD41 T cells in the lymphoproliferative abnormality
and 24 days of age: CD41 T cell±depleted (CTLA- of CTLA-42/2 mice.
41/1,1/2, n 5 24; CTLA-42/2, n 5 9), CD81 T cell±depleted
(CTLA-41/1,1/2, n 5 40; CTLA-42/2, n 5 8), and control CD41 T Cells Are Necessary for Lymphocyte
antibody-treated mice (CTLA-41/1,1/2, n 5 25; CTLA- Infiltration into Nonlymphoid Tissues
42/2, n 5 17) were compared. The genotype of the ctla-4 of CTLA-42/2 Mice
locus of these animals was determined by Southern blot CTLA-42/2 mice display dramatic infiltration of lymphoid
analysis of genomic DNA. CD81 T cell depletion was
cells into nonlymphoid tissues such as the liver, heart,
routinely more than 98% effective, and depletion of
lung, and pancreas, that reportedly results in a severe
CD41 T cells was routinely more than 95% effective
pancreatitis and fatal myocarditis in CTLA-42/2 animalswhen tested with RM4.4, an anti-CD4 monoclonal anti-
(Tivol et al., 1995; Waterhouse et al., 1995). These infil-body (MAb) that recognizes a different epitope than anti-
trates contain primarily CD31 T cells and F4/801 macro-CD4 GK1.5 MAb. However, some mice had a population
phages (Tivol et al., 1995). It is unknown whether thereof CD42CD82H571 T cells, which may be CD41 T cells
is a preferential infiltration of tissue-specific autoreac-that have down-regulated CD4 during antibody treat-
tive T cells into nonlymphoid tissues. Alternatively, lym-ment in vivo. Only mice that had fewer than 5%
phocyte infiltration into nonlymphoid vital organs mayCD42CD82H571 T cells were included in the analysis.
simply interfere nonspecifically with the function ofIt was important to maintain complete depletion from
these organs. Regardless, lymphocytic infiltration of thethe time of birth in order to prevent CD41 T cells from
nonlymphoid organs was not altered in CD81 T cell±becoming activated, because CD41 T cell depletion in
depleted CTLA-42/2 mice compared to controlantibody-vivo selectively removes naive resting CD41 T cells
treated or untreated CTLA-42/2 mice, showing that cyto-(Chace et al., 1994).
toxic CD81 T cells were not necessary in the destructionDepletion of CD81 T cells in the CTLA-42/2 mice had
of tissues in CTLA-42/2 mice. Extensive infiltration intono marked effect on the expansion of the CD41 T cells
the heart, liver, pancreas (Figure 4), and skin (data notcompared to untreated or control antibody-treated ani-
mals. The absolute number of CD41 T cells in the lymph shown) in the control and in the CD81 T cell±depleted
Immunity
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Figure 4. CD41 T Cell Depletion Prevents T
Cell Infiltration into Nonlymphoid Tissues
There was extensive lymphocyte infiltration
into nonlymphoid tissues in the control anti-
body-treated and CD81 T cell±depleted
CTLA-42/2 mice, whereas no infiltration was
evident in the CD41 T cell-depleted CTLA-
42/2 mice. Shown are tissue sections from
the liver and heart (A) and pancreas (B). The
tissues were formalin-fixed and stained with
hematoxylin and eosin by standard proce-
dures. Magnification, 2503 for all tissue sec-
tions.
CTLA-4 mice compared to the littermate CTLA-41/1,1/2 activation antigens consistent with an activated/mem-
ory cell phenotype (Figure 5B). However, CD81 T cellsmice was observed.
Remarkably, there was no evidence of lymphoid infil- from CTLA-42/2 mice continuously depleted of CD41 T
cells had a naive phenotype and expressed activation/tration into nonlymphoid organs in any of the CD41 T
cell±depleted CTLA-42/2 mice (Figure 4A, liver and memory cell surface markers at levels equivalent to the
littermate CTLA-41/2,1/1 animals (Figure 5D). These re-heart; Figure 4B, pancreas). These results indicate that
the CD41 T cells are necessary and sufficient for mas- sults suggest that there is a preferential activation of
CD41 T cells and that CD81 T cell activation is influencedsive lymphocyte infiltration in CTLA-42/2 mice. Further,
CD41 T cell±depleted CTLA-42/2 animals survived to 35 by CD41 T cells in the CTLA-4±deficient mice.
days of age (longest time tested), a time by which
all of the control antibody-treated CTLA-42/2 animals Cell Cycle Status of CD81 T Cells Is the Same
had died. in CD41 T Cell-Depleted CTLA-42/2
and Wild-Type Mice
The cell cycle status of the T cells in the T cell subset-CD81 T Cells Retain Naive Phenotype
in the Absence of CD41 T Cells depleted animals was examined by BrdU labeling stud-
ies. As shown in Figure 6A, there was a 3- to 4-foldin CTLA-4±Deficient Mice
One of the characteristics of the phenotype displayed increase in the percentage of BrdU1 CD41 T cells com-
pared to the littermate controls in the control antibodyby the CTLA-42/2 mice is a high frequency of T cells
expressing activation/memory T cell surface markers (CTLA-41/1,1/2: 13% 6 2.9%, n 5 8; CTLA-42/2: 53% 6
4.3%, n 5 6) and CD81 T cell±depleted CTLA-42/2 (CTLA-(Tivol et al., 1995; Waterhouse et al., 1995; Chambers
et al., 1996). To examine whether there was a difference 41/1,1/2: 12% 6 2.3%, n 5 14; CTLA-42/2: 46% 6 9.5%,
n 5 6) animals. There was no difference in the percent-in the frequency of activated CD41 compared to CD81
T cells in control CTLA-42/2 mice and in mice depleted age of BrdU1 T cells between the littermate controls and
the CTLA-4±deficient animals when depleted of CD41 Tof T cell subpopulations, splenic and lymph node T cells
were analyzed for cell surface expression of activation cells (CTLA-41/1,1/2: 36% 6 4.6%, n 5 7; CTLA-42/2:
36% 6 2.1%, n 5 4), whereas there was a 2- to 3-foldantigens. Analysis of representative fluorescence-acti-
vated cell sorter (FACS) data of lymph node T cells from increase in the BrdU incorporation in the CTLA-4±
deficient animals in the control antibody-treated animalsantibody-treated animals is shown in Figure 5. In the
untreated or control antibody-treated mice, there was (CTLA-41/1,1/2, 18% 6 1.2%, n 5 10; CTLA-42/2, 40% 6
8.9%, n 5 5) (Figure 6B).a consistently higher percentage of CD41 T cells com-
pared to CD81 T cells displaying an activated pheno- Overall, however, there was a higher level of BrdU
incorporation in the CD81 T cells from the CD4-depletedtype. These cells are characterized as CD691, CD44hi,
Mel14lo, CD45RBlo (Figures 5A and 5C), CD251, and animals. The CD81 T cells may be attempting to fill the
unoccupied lymphocyte niche as a result of the CD41Sca1hi and have down-regulated the TCR (data not
shown). This phenotype could be seen even prior to T cell depletion. This type of expansion does not result
in alterations in the naive phenotype of these cells and ismarked skewing of the CD4/CD8 ratio, as early as 6
days of age, at which time no increase in the total cell postulated to be independent of TCR-mediated signals
(Sprent and Tough, 1994). Further, there was no sponta-number of splenocytes and only a modest increase (1.5-
to 2-fold) in the total lymph node cell number was ob- neous proliferation or lymphoproliferation of the CD81
T cells from these animals when placed in culture exserved. Similarly, the majority of the CD41 T cells in
the CD81 T cell±depleted CTLA-42/2 animals expressed vivo (data not shown).
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Figure 5. CD41 T Cell Depletion Prevents
Lymphocyte Activation in CTLA-4±Deficient
Mice
Lymph node T (LNT) cells were analyzed for
the expression of the indicated activation/
memory T cell surface markers. (A and B) Ex-
pression of cell-surface markers on CD41 T
cells in control antibody-treated and CD81 T
cell±depleted CTLA-42/2 and littermate mice.
(C and D) Expression of cell surface markers
on CD81 T cells in CD41 T cell±depleted
CTLA-42/2 and littermate mice. Light line,
profile of the CTLA-41/1,1/2 littermate ani-
mals; bold line, profile of CTLA-42/2 mice.
Blocking CD28/B7 Interactions with CTLA-4Ig spleen or lymph node (Figure 7A). Further, there was no
increase in the percentage of CD691 CD44hi, Mel14lo,Prevents Activation and Proliferation
of CTLA-4±Deficient T Cells In Vivo CD45RBlo lymph node or splenic T cells (data not
To determine whether CD28/B7 interactions are neces-
sary for the activation and expansion of the CTLA-42/2
T cells in vivo, mice were injected with CTLA-4Ig. Daily
injections of CTLA-4Ig or control human IgG were given
to mice from birth and analyzed at 2 weeks of age (hu-
man IgG: CTLA-41/1,1/2, n5 11; CTLA-42/2, n 5 6; CTLA-
4Ig treated: CTLA-41/1,1/2, n 5 25; CTLA-42/2, n 5 6).
CTLA-4Ig treatment prevented lymphocyte expansion
in the CTLA-42/2 mice. There was no increase in abso-
lute cell number of the CD41 or CD81 T cells in the
Figure 7. CTLA-4Ig Treatment Prevents Lymphoproliferation in
CTLA-42/2 Mice
Mice were injected daily with CTLA-4Ig or human IgG control anti-
Figure 6. BrdU Incorporation by Lymph Node T Cells and B Cells body from birth and analyzed at 2 weeks of age
in Antibody-Treated CTLA-42/2 Mice (A) The absolute number of the CD41 and CD81 T cells in the control
antibody or CTLA±4Ig-treated age-matched mice. Each diamond(A) CD41 lymph node T (LNT) cells and (B) CD81 LNT cells from
control antibody-treated, CD81 T cell±depleted, and CD41 T cell- represents an individual animal.
(B) Representative data of the BrdU incorporation in CD41 or CD81depleted mice. Cells were stained with the antibodies to the indi-
cated cell surface markers, fixed, and stained with anti-BrdU anti- lymph node T cells in littermate control (light line) or CTLA-42/2 (bold
line) animals treated with the indicated antibodies. LNT, lymph nodebody. Light line, profile of the CTLA-41/1,1/2 littermate animals; bold
line, profile of the CTLA-42/2 mice. T cells.
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shown). These results confirm and extend a recent re-
port in which it was shown that CTLA-4Ig treatment in
vivo prevented lymphocyte infiltration and up-regula-
tion of CD69 and CD25 expression in CTLA-42/2 animals
(Tivol et al., 1997). Blocking the CD28-B7 interactions
also prevented increased BrdU incorporation by T cells
in the CTLA-42/2 mice compared to the littermate con-
trols (Figure 7B). All of the CTLA±4Ig-treated mice had
a higher percentage of BrdU1 CD81 T cells compared
to the CD41 T cells, as described for wild-type mice
(Figure 2), indicating that CD28/B7-mediated costimula-
tion was not involved in the inherent differences in CD81
and CD41 T cell turnover invivo inyoung normal animals.
These results indicate that a CD28-mediated signal was
necessary for the lymphoproliferation and that other
possible costimulatory molecules could not compen-
sate for CD28/B7 interaction.
Collectively, these results demonstrate that CD28-
dependent activation of CD41 T cells in vivo is the
primary event responsible for the T cell phenotype ob-
served in CTLA-42/2 animals. Although other mecha-
nisms may play a role in controlling the absolute number Figure 8. B Cell Activation in CTLA-42/2 Mice Is Due to CD28-
of CD81 T cells in untreated CTLA-42/2 mice, such as Dependent Activation of CD41 T Cells
apoptosis of T cell blasts, our results indicate that differ- (A) Absolute number of lymph node (LN) B2201 cells in CTLA-
ences in the frequency of activated cellsand subsequent 41/2,1/1 versus CTLA-42/2 animals from control antibody-treated,
CD41 or CD81 T cell±depleted and CTLA±4Ig-treated mice. Controlexpansion of the CD41 compared to CD81 T cells is
antibody-treated: CTLA-41/1,1/2, n 5 11, CTLA-42/2, n 5 11; CD81mainly responsible for the skewing of the CD4/CD8 ratio.
T cell±depleted: CTLA-41/1,1/2, n 5 11, CTLA-42/2, n 5 5; CD41 T
cell±depleted: CTLA-41/1,1/2, n 5 17, CTLA-42/2, n 5 6; and CTLA-
Expansion of B Cells Is Secondary to 4Ig treated: CTLA-41/1,1/2, n 5 18, CTLA-42/2, n 5 5. Each diamond
CD28-Dependent Activation of CD41 represents an individual animal.
T Cells in CTLA-42/2 Mice (B) BrdU incorporation by LN B2201 B cells in CTLA-42/2 (bold line)
and littermate (light line) mice in CD81 or CD41 T cell±depleted miceThe expression of CTLA-4 has been reported to occur
or mice treated with control human IgG antibody or CTLA-4Ig.on B cells stimulated in vitro (Kuiper et al., 1995), and
small amounts of CTLA-4 mRNA were observed in lipo-
polysaccharide blasts (Brunet et al., 1987). A large por-
Discussiontion of B cells in the CTLA-42/2 mice are blasts that have
up-regulated B7.2, Fas, CD5 (Waterhouse et al., 1995),
In this report we demonstrate that CD41 T cells mediateand MHC class II and are Mel14lo (data not shown).
the lymphoproliferative disorder in CTLA-42/2 mice.Further, B2201 B cells in the spleen and lymph node
Depletion of CD81 T cells in CTLA-42/2 mice had noincrease in absolute number in CTLA-42/2 mice (Figure
marked effect on the onset or on the severity of the8A), and an increased incorporation of BrdU in the
lymphoproliferative disorder in these animals comparedsplenic and lymph node B cells in the CTLA-42/2 mice
to untreated or control antibody-treated animals. How-compared to littermate controls (Figure 8B) is evident.
ever, all of the characteristic lymphoproliferation andTo determine whether CTLA-4 plays a direct role in regu-
pathogenesis in the CTLA-42/2 mice was prevented bylating B cell proliferation, splenic and lymph node B cells
the continuous depletion of CD41 T cells. We used anti-in the T cell±depleted and CTLA±4Ig-treated mice were
body-mediated depletion in vivo to study the mecha-examined. CD81 T cell depletion did not alter the in-
nisms involved in the development of the lymphoproli-crease in absolute cell number or the proportion of
ferative disorder in CTLA-42/2 mice instead of TCRBrdU1 B2201 B cells in CTLA-4±deficient animals. How-
transgenic CTLA-42/2 mice to maintain an unmanipu-ever, these increases were completely abrogated by
lated polyclonal TCR repertoire in the remaining T cellthe depletion of CD41 CTLA-42/2 T cells (Figure 8). The
subset.phenotype of the B cells in CD41 T cell±depleted mice
We feel that this approach has advantages over usingwas indistinguishable from the phenotype of littermate
CTLA-42/2 mice expressing any single TCR transgene.controls (data not shown). The abnormal B cell expan-
First, the spontaneous proliferation in the absence ofsion in the CTLA-42/2 mice was also prevented in CTLA-
CTLA-4 could be influenced by the affinity of the TCR42/2 mice treated with CTLA-4Ig (Figure 8). These results
used in the transgenic animals, making the results diffi-demonstrate clearly that the activation and expansion
cult to interpret. Second, lack of spontaneous activationof the B cells in the CTLA-42/2 mice are secondary to
in vivo by T cells expressing a single TCR transgene inthe CD28-dependent activation and expansion of the
CTLA-42/2 mice might be attributed to the preventionCD41 T cells, most likely as a result of the increased
of escape of autoreactive clones during thymocyte de-cytokine production and T±B interactions, and they sug-
velopment. The observation that CD81 T cells pos-gest that CTLA-4 does not directly function to regulate
B cell homeostasis. sessing the endogenous TCR repertoire maintain a naive
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phenotype and do not expand in CTLA-42/2 mice in the influenced by the rate of transcription and mRNA stabil-
absence of peripheral CD41 T cells provides the most ity (Freeman et al., 1992; Perkins et al., 1996; Finn et al.,
compelling evidence that the lymphoproliferative disor- 1997) and protein export and endocytosis (Leung et al.,
der is initiated by CD41 T cells. 1995; Alegre et al., 1996; Linsley et al., 1996; Chuang et
al., 1997; Shiratori et al., 1997; Zhang and Allison, 1997),
and it is possible that expression patterns and the mech-
CD81 T Cells Are Not Activated and Do Not anism(s) important for regulation may be distinct for
Expand in the Absence of CD41 T Cells different T cell subpopulations.
in CTLA-42/2 Mice This possibility has important functional implications.
The eventual activation of CD81 T cells in the unmanipu- Proliferation of total lymph node T cells, of which ap-
lated CTLA-4±deficient mice may occur as a result of proximately one third are CD81, and purified TCR
cytokine secretion by CD41 T cells, including IL-4 and transgenic CD81 T cells was inhibited when CD3, CD28,
interferon-g, and subsequent up-regulation of MHC and and CTLA-4 were antibody cross-linked (Walunas et al.,
B7 expression. Hence, the failure of CD81 T cells to 1994; Krummel and Allison, 1995). The ability of CTLA-4
expand in the absence of CD41 T cells in CTLA-42/2 cross-linking to inhibit CD3 plus CD28-mediated T cell
mice might be due to the lack of adequate cytokines to expression of activation markers CD69 and CD25, IL-2
support the expansion of CD81 T cells. However, several secretion and progression into the S/G2 phase of the
observations make this an unlikely mechanism. First, cell cycle has also been demonstrated for CD41 (Krum-
although limiting cytokine availability has been shown mel and Allison, 1996) and CD81 (Walunas et al., 1996)
to regulate antigen-specific and allogeneic proliferative lymph node T cells in vitro. Although inhibition of the T
responses by purified naive CD81 T cells when stimu- cell response was observed in both reports, there were
lated in vitro (Kronin et al., 1996), the CD81 T cells in several differences in these experiments. CTLA-4 cross-
these cultures became activated blasts and expanded linking had no detectable effect 24 hr after activation of
during the first 3 days of culture in the absence of exoge- CD81 T cells (Walunas et al., 1996), whereas marked
nous cytokines. Further, the addition of exogenous CTLA±4-mediated inhibition was observed for all param-
IL-2 supported continued expansion of the CD81 T cells, eters examined 12±24 hr after stimulation of CD41 T
but it did not alter the kinetics of T cell response or the cells (Krummel and Allison, 1996). Further, differences
initial proliferative response. In contrast, the CD81 T in the ability of exogenous IL-2 to reverse CTLA±4-medi-
cells in the CD41 T cell±depleted CTLA-42/2 animals are ated inhibition of CD25 expression and cell cycle pro-
not blasting, do not express activation markers such as gression were reported (Krummel and Allison, 1996; Wa-
CD69 and CD25, have not down-regulated their TCRs,
lunas et al., 1996). It will be necessary to determine
and do not have a higher percentage of BrdU1 cells
whether theCTLA-4 cell surface expression and traffick-
compared to littermate controls. Collectively, these re-
ing patterns are different in CD41 and CD81 T cells
sults indicate that these cells have not received activat-
to appreciate fully the role of CTLA-4 in regulating the
ing TCR-mediated and CD28-mediated signals. Second,
initiation and duration of antigen-specific T cell re-
since the CD81 T cells in the CD41 T cell±depleted mice
sponses and, conversely, the prevention of activation
have not up-regulated CD25, these cells are presumably
in these T cell subsets.not responsive to IL-2. Third, even in the untreated
CTLA-42/2 animals, in which abnormal levels of cyto-
kines are secreted by the activated T cells, the absolute
Differential Regulation of CD41 and CD81number of CD81 T cells does not expand to the same
T Cell Activationextent as the CD41 T cells. Thus, it is extremely unlikely
T cell activation is controlled by TCR signaling uponthat the failure of the CD81 T cells to expand in the
binding to MHC/peptide complexes (signal 1) and co-CD41 T cell±depleted CTLA-42/2 mice was due solely
stimulation (signal 2). The molecular basis for the prefer-to the insufficient helper T cell-derived cytokines.
ential activation of the CD41 T cells in the absence of theAlthough the CD81 T cells remain unactivated in vivo
inhibitory component of signal 2 is not clear, although itin the CTLA- 42/2 mice in the absence of CD41 T cells,
is possible that CTLA-4 signaling may bisect a signalingthis observation does not imply that CTLA-4 does not
pathway involved in CD4-mediated signal transduction.play a role in regulating CD81 T cell responses. Previous
CD4 or CD8 coreceptors act to stabilize the TCR/MHC/results demonstrate that CTLA-4 is expressed at higher
peptide interaction and transduce signals coupled tolevels on the cell surface of murine CD81 versus CD41
the TCR via Src-family tyrosine kinases Lck and FynT cells when activated in vitro (Walunas et al., 1994;
(reviewed by Janeway and Bottomly, 1994). CoreceptorKrummel and Allison, 1995). However, it has not been
engagement in the TCR/MHC complex has been showndetermined if the absolute protein levels differ between
to alter the TCR threshold and the functional outcomeCD41 and CD81 T cells, because the majority of CTLA-4
of that response (Sloan-Lancaster et al., 1993; Vidal etprotein is sequestered inside the cell (Leung et al., 1995;
al., 1996; Madrenas et al., 1997). Several observationsLinsley et al., 1996). Moreover, CTLA-4 cell surface ex-
suggest that CD4 and CD8 signaling differ. Tyrosinepression was examined only 48 hr after activation in
kinase Lck can associate with CD4 and CD8 (Veillettethese studies (Walunas et al., 1994; Krummel and Alli-
et al., 1988); however, interaction of Lck with CD4 isson, 1995). The kinetics of the CTLA-4 expression pat-
more efficient than with CD8, with 80%±95% of the cellu-terns on CD41 compared to CD81 T cells and the activa-
lar Lck associated with CD4 in primary T cells (Veillettetional requirements in vitro and in vivo have not been
determined. Cell surface CTLA-4 protein expression is et al., 1989; Luo and Sefton, 1990). CD4 cross-linking
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also results in higher levels of Lck tyrosine phosphoryla- but low levels of TCR signaling may be required to main-
tain an activated state of regulatory signaling molecules.tion (Campbell et al., 1995). CD4/TCR cross-linking gen-
erates higher levels and a unique pattern of phosphory- It is also conceivable that a mechanism exists to prevent
rampant activation or expansion of the cells as a resultlated proteins compared to CD8/TCR cross-linking
(Ravichandran and Burakoff, 1994). Finally, cross-linking of this low-avidity interaction. Previously, we have pro-
posed a two-signal model for T cell activation, in whichtyrosine phosphatase CD45 has dramatic effects on the
anti-TCR antibody-induced signals on naive CD41 but signal 2 is a summation of positive and negative costim-
ulatory signals mediated by CD28 and CTLA-4, respec-not CD81 lymph node T cells (Maroun and Julius, 1994).
It will be important to determine whether differences in tively (Chambers et al., 1996). In this model, under condi-
tions where only limiting amounts of B7 ligands arethe coreceptor signaling play a role in the preferential
activation of CD41 T cells in the CTLA-4±deficient mice. available, the CTLA-4 signal would dominate and pre-
vent T cell activation. Based on the phenotype of the
CTLA-42/2 mice, we extended this model to include
The Role of Costimulation in Lymphoproliferation dominant inhibitory signals when T cells interact with
in CTLA-42/2 Mice self-MHC/peptide during tonic interactions (Chambers
CD28/B7 interaction was required for T cell activation and Allison, 1997). Based on the results presented here,
in the CTLA-42/2 mice (Tivol et al., 1997; Figure 7). This it appears that there is a differential requirement for the
could be due to preventing CD28 signal transduction inhibitory CTLA±4-mediated signals to maintain a naive
or indirectly by obstructing cell±cell interactions. Mice phenotype in the presence of self-MHC and resting lev-
deficient in both B7.1 and B7.2 do not develop a lympho- els of B7 between CD41 and CD81 T cells. These results
proliferative disorder similar to CTLA-42/2 animals (Bor- have important ramifications not only for understanding
riello et al., 1997), suggesting that CD28 signaling itself the biochemical basis of signal transduction pathway
is important for the disease progression in CTLA-42/2 involved in peripheral T cell homeostasis but also for
mice. Thus, the lack of activation of the CD81 T cells understanding the generation of an antigen-specific re-
in CD41 T cell±depleted animals could be a result of sponse in vivo. It may be that because CD41 T cells
inadequate stimulation via the TCR or CD28-mediated provide important help for humoral and cytotoxic re-
costimulation. Naive CD81 T cells have been shown sponses, the maintenance of the resting state for naive
to require higher levels of B7 than CD41 T cells when CD4 T cells is more dependent on actively inhibiting
stimulated in vitro (Deeths and Mescher, 1997). It will activational signals, thereby facilitating a rapid response
be important to determine whether the CD81 T cells in the event of increased signal 1 or positive costimula-
in the CD41 T cell±depleted CTLA42/2 mice become tion. In addition, the generation of harmful inappropriate
activated with increased CD28/B7 interactions, for ex- cytotoxic effector responses would be less likely to oc-
ample, in mice expressing high levels of B7 on resting cur in the event of subtle alterations in the ligand densi-
lymphocytes in vivo (Fournier et al., 1997) or in the pres- ties or avidities involved in either signal 1 or signal 2.
ence of increased antigenic load, such as in older an- In conclusion, our results provide evidence that CD41
imals. and CD81 T cells may be affected differentially by the
absence of negative costimulation in vivo. These results
have implications for elucidating the mechanisms re-
The Role of CTLA-4 in Peripheral sponsible for the lymphoproliferative disorder in CTLA-
T Cell Homeostasis 4±deficient mice and for understanding the regulation
The peripheral T cell pool can be maintained in the ab- of peripheral T cell homeostasis of CD41 compared to
sence of new thymic emigrants once the full comple- CD81 T cells in vivo.
ment of the TCR repertoire has been established (re-
viewed by Sprent and Tough, 1994). The TCR repertoire Experimental Procedures
and the absolute number of T cells remain relatively
Miceconstant throughout the life of the animal. T cell division
CTLA-42/2 mice were generated as described (Chambers et al.,occurs as part of the normal cell turnover as well as
1997). Offspring from (B6 3 129) backcrossed to B6 that were in-
in response to specific antigen. Thus, once the TCR terbred to generate litters containing homozygous animals were
repertoire, and thereby the TCR signaling threshold, used for the majority of the experiments. Animals were typed for
have been established by positive and negative selec- the genotype of the ctla-4 gene by Southern blot analysis (Chambers
et al., 1997). Animals backcrossed five times to B6 or 129 or fourtion in the thymus, there is a balance between TCR-
times to BALB/c were also tested. Animals were maintained in mi-mediated activation of peripheral T cells to self-MHC/
croisolators in accordance with the animal care and use regulationspeptide required for the survival of these cells and the
of the University of California, Berkeley. No differences were ob-
response to self-MHC/foreign peptides necessary to served between littermates wild-type or heterozgous for CTLA-4
provide effective immune responses. Tonic interaction mutation.
with self-MHC for survival has been demonstrated in
vivo for both CD41 and CD81 T cells (Takeda et al., Media and Reagents
RPMI (BioWhittaker) was supplemented with 10% calf serum1996; Tanchot et al., 1997). Further, possible differences
(Hyclone, Logan, UT), 2 mM 2-mercaptoethanol (Sigma, St. Louis,between requirements for naive versus memory T cells
MO), 2 mM L-glutamine, and 100 U/ml antibiotics (Gibco). BrdU wasare just beginning to be appreciated (Tanchot et
purchased from Sigma.
al., 1997). Following purchased MAbs were used: anti-CD4-phycoerythrin
The molecules and biochemical signals required for (PE) (clones H129 and RM4.4), anti-CD8b-PE, anti-CD44-PE, H57-
biotin, anti-CD69-fluorescein isothiocynate (FITC)/biotin, anti-this peripheral T cell homeostasis are as yet unknown,
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CD25-FITC, anti-CD28-biotin,anti-CD5-biotin, anti-Thy1.2-PE/FITC, Acknowledgments
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